General Announcement::Company Statement

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS UK PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-Aug-2026 14:08:50
Status
New
Announcement Sub Title
Company Statement
Announcement Reference
SG260825OTHRQXXG
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
25/08/2026 09:00:00
Description (Please provide a detailed description of the event in the box below)
Biocon Announces Pegfilgrastim Biosimilar Marketing Approval by Japan Ministry of Health, Labour and Welfare (MHLW)

Attachments

Biocon_Peg_Japan_SGX_25082026.pdf
Total size =379K